News & Analysis on Clinical Trial Services & Contract Research And Development
One of the difficulties facing the pharmaceutical industry is the sheer volume of information that has to be incorporated on drug labelling and packaging, which often makes designing packaging more a function of squeezing in material, rather than...
The latest research included in the proceedings of the annual meeting of the European Society of Cardiology, (ESC) means that heart treatments and management therapies feature strongly in DrugResearcher's round-up of the 5-day conference.
Thermo Electron introduces its new mass spectrometer, which uses a linear ion trap delivering faster cycle times and improved ion statistics. This latest addition to the ion trap product portfolio is designed for use in both research and routine...
Pharmos has announced the initiation of a phase I trial with cannabinor, a CB2-selective synthetic cannabinoid drug candidate. The trial aims to assess the drug's potential as a treatment for neuropathic, inflammatory, visceral, and post-surgical pain.
A suite of optical detection methods, developed by Finnish researchers alongside world number two drugmaker GlaxoSmithKline, promises to cut the cost of drug production and increase the safety and quality of medicinal products.
Scientists in the US have developed a way to rapidly generate libraries of gold nanoparticles that could have an array of applications in the pharmaceutical industry, from target and drug discovery studies to drug delivery.
Excipients, often overlooked by pharmaceutical companies with their attention firmly focused on active pharmaceutical ingredients, are benefiting from an increasing awareness of their potential to cut the costs of drug development.
Akzo Nobel business unit Diosynth, which specialises in the production of complex active biopharmaceutical ingredients for the pharmaceutical sector, has won a contract to apply its new method for manufacturing synthetic peptides that, it claims,...